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Abstract
Urinary citrate (Ucit) protects against urinary stone formation. Acid base sta-
tus and diet influence Ucit. However, the effect of demographics, diet, and
glucose metabolism on Ucit excretion, urinary pH (U-pH) and net gastroin-
testinal alkali absorption (NAA) are not known. Twenty-four hour urine
samples, blood glucose, creatinine, and cystatin C were obtained from non-
Hispanic white sibships in Rochester, MN (n = 446; 64.5  9 years; 58%
female). Diet was assessed by a food frequency questionnaire. The impact of
blood glucose, demographics and dietary elements on Ucit excretion, U-pH,
and NAA were evaluated in bivariate and multivariable models and interaction
models that included age, sex, and weight. NAA significantly associated with
Ucit and U-pH. In multivariate models Ucit increased with age, weight,
eGFRCys, and blood glucose, but decreased with loop diuretic and thiazide
use. U-pH decreased with serum creatinine, blood glucose, and dietary protein
but increased with dietary potassium. NAA was higher in males and increased
with age, weight, eGFRCys and dietary potassium. Significant interactions were
observed for Ucit excretion with age and blood glucose, weight and eGFRCys,
and sex and thiazide use. Blood glucose had a significant and independent
effect on U-pH and also Ucit. This study provides the first evidence that
blood glucose could influence urinary stone risk independent of urinary pH,
potentially providing new insight into the association of obesity and urinary
stone disease.
Introduction
Kidney stones are common, affecting up to 10% of people
during their lifetime (Scales et al. 2012). Citrate is
thought to be an important crystallization inhibitor, and
oral potassium citrate is often a first line of treatment for
preventing stone recurrence (Pearle et al. 2014). Citrate
complexes with filtered calcium, and also has independent
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effects at the crystal surface to inhibit calcium oxalate and
brushite crystal growth (Ryall 1997; Pearle et al. 2014).
Some filtered citrate is reabsorbed in the proximal tubule,
largely regulated by proximal tubule cell pH (Zuckerman
and Assimos 2009). Hypocitraturia is found in 20–60% of
stone formers (Zuckerman and Assimos 2009). Treatment
is of the underlying disorder as well as administration of
potassium citrate which is thought efficacious for hypoci-
traturia caused by distal renal tubular acidosis (RTA),
chronic diarrheal syndrome, and/or thiazide-induced
hypokalemia (Zuckerman and Assimos 2009).
Daily acid generation is greatly influenced by diet
(Sakhaee et al. 1993), making it an important factor when
evaluating a kidney stone patient. Urinary pH is also an
important factor in stone risk, with higher values favoring
calcium phosphate stones and lower ones uric acid stones
(Pearle et al. 2014). Although final urine pH is associated
with acid load, it is also influenced by ammonium excre-
tion and the ability of the distal tubule to acidify the col-
lecting duct. Overall factors that influence urine pH and
citrate are similar, but not identical.
Stone formers with noninsulin dependent diabetes mel-
litus have a higher frequency of uric acid stones than
nondiabetic stone formers (Sakhaee 2014), in part due to
effects of insulin resistance on urinary ammonium levels
(Li et al. 2014). However, the independent effect of blood
glucose on urinary citrate excretion has not been deter-
mined. Furthermore, while urinary citrate and urine pH
are important in kidney stone pathogenesis, very few
studies have examined the effects of demographics on
either (Hosking et al. 1985; Trinchieri et al. 1992). Also,
studies to date have relatively small sample sizes, present
conflicting evidence, or have not accounted for diet. In
this study, we took advantage of detailed demographic,
environmental, and urinary data in a well characterized
cohort to examine the determinants of urinary pH, citrate
excretion, and net gastrointestinal alkali absorption.
Methods
This study was approved by the Mayo Clinic Institutional
Review Board (Mayo IRB# 08-006238” Genetic Determi-
nants of Urine Lithogenicity - Working Protocol”).
GENOA cohort
The multi-phase Genetic Epidemiology Network of Arte-
riopathy (GENOA), a member of the Family Blood Pres-
sure Program (FBPP), recruited non-Hispanic white
hypertensive sibships from Rochester, Minnesota for link-
age and association studies to investigate the genetic
underpinnings of hypertension in Phase I (1996–2001)
(Daniels et al. 2004). The Genetic Determinants of
Urinary Lithogenicity (GDUL) study (2006–2012) is an
ancillary study of the Phase III GENOA Genetics of
Chronic Kidney Disease (CKD) study conducted in
GENOA participants (Rule et al. 2013). Participants in
the Rochester, MN GENOA cohort were invited to collect
24 h urine samples and complete a food frequency ques-
tionaire (FFQ, Viocare Technologies, Princeton, NJ)
(Kristal et al. 2014). Participants were excluded from this
study if they were in end-stage renal failure (stage 5
CKD).
Study visit
After informed consent, participants completed at least
one 24 h urine collection (Hess et al. 1997; Parks et al.
2002) and the FFQ at a CKD and/or GDUL study visit. A
total of 91 (20.4%), 202 (45.3%), and 153 (34.3%) partic-
ipants had a total of one, two, or three urine collections,
respectively. For individuals with two or three urine col-
lections, values were averaged for analysis. The mean time
between the earliest (CKD) and latest (GDUL) urine col-
lections was 1.73 years (range = 0.9–3.6 years). The aver-
age time between the two GDUL collections was 22 days.
Intraclass correlation coefficients (ICCs) for urine factors
across collections revealed that the majority of urine mea-
sures were relatively stable across time. The ICC for pH
was 0.50, for net alkali absorption was 0.39, and for
citrate was 0.65. Participants also completed a detailed
kidney stone questionnaire (to assess stone-forming status
and other medical comorbidities and risk factors), and
data from a GENOA CKD Study Questionnaire was avail-
able as needed.
Urine collection
Urine was collected with toluene as a preservative.
Twenty-four hour urinary concentration of citrate, urine
pH and other determinants of supersaturation were mea-
sured in the Mayo Clinic Renal Testing Laboratory.
Serum creatinine was assessed using a standardized enzy-
matic assay on a Roche Cobas chemistry analyzer (c311)
(Roche Diagnostics; Indianapolis) while cystatin C was
measured using an immunoturbidometric assay (Gentian;
Moss, Norway) that was traceable to an international ref-
erence material. Glomerular filtration rate (GFR) was
independently estimated using cystatin C (eGFRCys)
(Inker et al. 2012).
Descriptive statistics
Data management and statistical analyses were conducted
in SAS version 9.3 (SAS Institute Inc., Cary) (R Develop-
ment Core Team, 2008). Urine measures appeared to
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have relatively normal distributions; thus, no variable
transformations were applied. Values that were ≥4 stan-
dard deviations from the mean of any urine or diet mea-
sure were removed. Linear mixed effects models (LMM),
that included sibship as a random intercept (to properly
account for family structure), were used to test whether
there were significant differences by sex for the urinary
and diet measures.
Variable selection
A randomly selected, independent subset of the GENOA
cohort (one individual per sibship) was used for stepwise
linear regression to determine the variables that were
associated with urinary citrate, pH and net alkali absorp-
tion. Variables available for selection included: weight,
body mass index (BMI), smoking status (current- or
never smoker), diabetes status (yes/no), recent fasting
blood glucose level (within 1 year of the urine collection),
systolic blood pressure (SBP), diastolic blood pressure
(DBP), eGFRCys, diuretic loop use (yes/no), diuretic thi-
azide use (yes/no), and dietary animal protein, sodium,
calcium, fructose, oxalate, total protein, and sucrose
intakes. Net alkali absorption was calculated using the Oh
method: (Urine(Na + K + Ca + Mg)-(Cl + 1.8P))(Oh
1989). The entry criterion for stepwise selection was
P < 0.05, and the exit criterion was P > 0.10. Variables
that are known to strongly influence urinary citrate (age,
sex, serum creatinine, and dietary potassium) were forced
into each model.
Relationships between urinary chemistries
To evaluate and visualize the relationship between citrate
and net alkali absorption (Fig. 1), pH and net alkali
absorption (Fig. 2), and pH and citrate (Fig. 3), a two-
stage modeling approach was used. In stage one, the urine
chemistries of interest were first adjusted for variables
from the stepwise selection process, separately. The mean
value of the urine chemistry variable was then added back
to the raw residuals, and the resulting adjusted residuals
were used as either the exposure or outcome variables for
stage two. The stage two model included the adjusted
residuals of citrate (Figs. 1 and 3) or pH (Fig. 2) from
stage one as the dependent variable, and the adjusted
residuals of net alkali absorption (Figs. 1 and 2) or pH
(Fig. 3) from stage one as the independent variable. The
dependent and independent variables were then plotted in
a scatter plot, and linear regression lines were overlaid.
Association testing
After variable selection, LMM was performed on the
GENOA subset sample with complete data on all selected
variables (n = 446) to assess significant predictors of the
urinary measures, accounting for the sibship structure in
Figure 1. Urinary citrate versus net alkali absorption. Adjusted urinary citrate was significantly, positively associated with adjusted net alkali
absorption (b = 4.7062; P < 0.0001). Urinary citrate was adjusted for age, sex, serum creatinine, dietary potassium intake, weight, blood
glucose, eGFRcys, diuretic loop use, and diuretic Thiazide use. Net alkali absorption was adjusted for age, sex, serum creatinine, dietary
potassium, eGFRcys, and diuretic loop use.
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GENOA. Interaction models were also conducted to
assess age, sex, and weight (if weight was included in the
model selection as a predictor) interactions with the vari-
ables included in the models. Interactions were considered
significant at an alpha level of 0.05. Sensitivity analyses
were performed by running the final multivariable models
in the subset of participants with no history of kidney
stones to assess direction and significance of the final
variables.
Interaction plots
Fig. 4A–D were created to visualize the blood glucose x
age (4A); eGFRcys x weight (4B); and sex x thiazide
Figure 2. Urine pH versus net alkali absorption. Adjusted urine pH was significantly, positively associated with adjusted net alkali absorption
values (b = 0.009; P < 0.0001). Urine pH was adjusted for age, sex, serum creatinine dietary potassium intake, blood glucose, diuretic loop use,
and dietary protein intake. Net alkali absorption was adjusted for age, sex, serum creatinine, dietary potassium, eGFRcys, and diuretic loop use.
Figure 3. Urinary citrate versus urine pH. Adjusted urinary citrate was not significantly associated with urine pH (b = 40.18; P = 0.10). Urinary
citrate was adjusted for age, sex, serum creatinine, dietary potassium intake, weight, blood glucose, eGFRcys, diuretic loop use, and diuretic
Thiazide use. Urine pH was adjusted for age, sex, serum creatinine dietary potassium intake, blood glucose, diuretic loop use, and dietary
protein intake.
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diuretic use (4C) interactions on urinary citrate excre-
tion, as well as the interaction between loop diuretic use
and weight on net alkali absorption (4D). Multivariable
regression models that included the stepwise selection
variables were run for each interaction. To calculate pre-
dicted urinary outcome, the beta estimates for continu-
ous predictor variables were multiplied by the mean
value for the respective variable from the sample, and
for dichotomous variables, the reference group was used
where appropriate (i.e., female, not taking diuretics).
Three values for the continuous variables of interest (age
and blood glucose (Fig. 4A); eGFRcys and weight
(Fig. 4B and D) were obtained by taking the mean value
of each of the variables, and the mean value adding or
subtracting one standard deviation. These values were
used to produce nine predicted urinary citrate values (at
each of the three values for the two variables of interest)
that were plotted in the interaction plots for blood glu-
cose x age (Fig. 4A) and eGFRcys x weight (Fig. 4B) and
six predicted net alkali absorption values for the weight
x loop diuretic use interaction (Fig. 4D). For the sex x
thiazide diuretic use plot (Fig. 4C), four predicted uri-
nary citrate excretions were calculated to create the
interaction plot (females taking diuretics, males taking
diuretics, females not taking diuretics, males not taking
diuretics).
Results
Descriptive statistics
A total of 446 individuals from 303 sibships participated
in this study (Table 1). The sibship structure of the sam-
ple was as follows: 198 singletons, 82 sibpairs, 15 sibships
with 3 siblings and 8 sibships with 4 or more siblings.
The mean age was 64.5  9 years and 58% of the partici-
pants were female. Three individuals took potassium
citrate medication. Out of 446 participating individuals,
400
450
500
550
600
650
700
750
–1 SD from mean
glucose
Mean glucose +1 SD from mean
glucose
Pr
ed
ic
te
d 
ur
in
ar
y 
ci
tr
at
e
ex
cr
et
io
n 
(m
g/
d)
Blood glucose level
A  Glucose * age on urinary citrate excretion
–1 SD from mean
age Mean age
+1 SD from mean
age
400
500
600
700
800
900
1000
1100
–1 SD from mean
eGFR
Mean eGFR +1 SD from mean
eGFR
Pr
ed
ic
te
d 
ur
in
ar
y 
ci
tr
at
e
ex
cr
et
io
n 
(m
g/
d)
eGFRcys
B  eGFRcys * weight on urinary citrate excretion
–1 SD from mean
weight Mean weight
+1 SD from mean
weight
0
100
200
300
400
500
600
700
800
Female Male
Pr
ed
ic
te
d 
ur
in
ar
y 
ci
tr
at
e
ex
cr
et
io
n 
(m
g/
d)
Sex
C  Sex * Thiazide diuretic use on urinary citrate excretion
Not taking Thiazide diuretic Taking Thiazide diuretic
46
48
50
52
54
56
58
60
62
64
Not taking loop diuretic Taking loop diuretic
Pr
ed
ic
te
d 
ne
t a
lk
al
i
ab
so
rp
tio
n 
(m
Eq
/d
)
Loop diuretic use
D  Weight * diuretic loop use on urinary net alkali absorption
–1 SD from mean weight Mean weight +1 SD from mean weight
Figure 4. Interaction models. (A) Age and blood glucose on urinary citrate excretion. Higher age decreased the effect of blood glucose on
urinary citrate excretion (bage x blood glucose = 0.20, P = 0.01). SD, age (years), blood glucose (mg/dL). (B) eGFRCys and weight on urinary citrate
excretion. Higher weight increased the effect of eGFRCys on urinary citrate excretion (bweight x eGFRcys = 0.07, P = 0.01). eGFRcys: estimated
Glomular Filtration Rate (mL/min/1.73 m2), weight in kg, SD. (C) Sex and Thiazide diuretic use on urinary citrate excretion. Thiazide use
decreased urinary citrate excretion more in males than females (bsex x thiazide use = 114.22, P = 0.04). SD. (D) Weight and loop diuretic use on
net alkali absorption. Individuals taking loop diuretics showed increased net alkali absorption as weight increased, while those not taking loop
diuretics showed a decreased net alkali absorption as weight increased. (bweight x loop diuretic use = 0.45, P = 0.04).
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408 provided information on kidney stone history, of
whom 47 (11.5%) had reported a history of stones, con-
sistent with stone prevalence in the general population
(Pearle et al. 2014). Sensitivity analyses performed in the
subset of nonstone formers showed consistent results
(direction and significance) for each of the multivariable
models.
Relationships between urinary chemistries
Urinary citrate, adjusted for age, sex, serum creatinine,
dietary potassium intake, weight, blood glucose, eGFRcys,
and diuretic use, was significantly and positively associ-
ated with net gastrointestinal alkali absorption, adjusted
for age, sex, weight, serum creatinine, dietary potassium
intake, eGFRcys, and loop diuretic use (b = 4.70;
P < 0.0001). Urine pH adjusted for age, sex, serum crea-
tinine dietary potassium intake, blood glucose, loop
diuretic use, and dietary protein intake also positively
associated with adjusted net gastrointestinal alkali absorp-
tion (b = 0.009; P < 0.0001). However, adjusted citrate
and adjusted urine pH were only weakly and not signifi-
cantly associated (b = 40.18; P = 0.10).
Association testing
In the bivariate analysis (Table 2) there was an age-related
decline in urinary citrate. Males had significantly higher
urinary citrate, higher net alkali absorption and lower pH
than females. Urinary citrate was positively associated
with weight, eGFRCys, and blood glucose, and negatively
associated with serum creatinine and loop diuretic use.
Urinary pH decreased with increasing serum creatinine
and blood glucose, and was also decreased for those tak-
ing loop diuretics.
In the multivariable model (Table 3) urinary citrate
increased with age, weight, eGFRCys, and blood glucose,
and decreased with loop diuretic and thiazide use. Urine
pH decreased with serum creatinine, blood glucose and
dietary protein and increased with dietary potassium.
Net alkali absorption was higher in males and increased
with age, weight, eGFRCys and dietary potassium.
Table 1. Descriptive statistics.
Combined
n = 446
Female
n = 259
Male
n = 187
P-valueMean (SD) or n (%) Mean (SD) or n (%) Mean (SD) or n (%)
Age, year 64.5 (9.0) 63.4 (9.1) 66.1 (8.7) 0.0077
Weight, kg 88.7 (19.8) 81.8 (18) 98.2 (18.3) <0.0001
BMI, kg/m2 31.0 (6.0) 30.7 (6.5) 31.4 (5.2) 0.222
Serum creatinine, mg/dL 0.8 (0.2) 0.8 (0.2) 1.0 (0.2) <.0001
eGFRCys, mL/min/1.73 m
2 86.8 (24.6) 90.0 (25.5) 82.3 (22.6) 0.0081
History of stone formation1 47 (11.5) 21 (8.8) 26 (15.3) 0.0482
Diabetes status 0.0125
Yes 55 (12.3) 23 (8.9) 32 (17.1)
No 391 (87.7) 236 (91.1) 155 (82.9)
Blood glucose, mg/dL 95.2 (18.9) 92.8 (19.1) 98.6 (18.1) 0.012
Dietary measures
Total protein, g/day 80.6 (33.9) 75.2 (29.6) 88.1 (38.0) <.0001
Potassium, mg/day 3164.7 (1269.8) 3138.1 (1255.7) 3201.6 (1291.6) 0.5941
Diuretic use
Loop 0.2321
Yes 18 (4.0) 13 (5.0) 5 (2.7)
No 428 (96.0) 246 (95.0) 182 (97.3)
Thiazide 0.9228
Yes 166 (37.2) 96 (37.1) 70 (37.4)
No 280 (62.8) 163 (62.9) 117 (62.6)
Urinary traits
Citrate, mg/day 578.9 (320.1) 542.2 (284.7) 629.6 (358.2) 0.0017
pH 6.2 (0.5) 6.3 (0.5) 6.1 (0.5) 0.0004
Net alkali absorption, mEq/day 71.0 (25.2) 64.5 (21.6) 80.0 (26.9) <0.0001
P-values were testing for sex differences, using linear mixed models to account for sibships.
SD, standard deviation, BMI, body mass index, eGFR, estimated Glomerular Filtration Rate (cystatin calculation).
1
Total sample size for history of stone formation is 408.
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Three significant interactions were observed (Fig. 4A–C)
for urinary citrate excretion including age and blood glu-
cose (b = 0.20, P = 0.01), weight and eGFRCys (b = 0.07,
P = 0.01), and sex and thiazide use (b = 114.22,
P = 0.04). One significant interaction for net alkali absorp-
tion with weight and loop diuretic use was also observed
(Fig. 4D; b = 0.45, P = 0.04).
Discussion
In this study, we assessed the effects of demographics,
metabolic parameters, and diet on urinary citrate, pH,
and net alkali absorption. As previously described, net
gastrointestinal alkali absorption influenced urinary citrate
(Sakhaee et al. 1993), as well as urinary pH. We also
found that a higher fasting glucose was associated with a
lower urinary pH, but a higher urinary citrate. This
observation may shed new insights into the association of
obesity and diabetes with urinary stone risk, especially for
uric acid stones.
After adjusting for covariates, urinary citrate increased
with age, consistent with observations from a recent study
restricted to stone formers alone (Friedlander et al. 2014).
Hosking and colleagues also observed an increased citrate
excretion with age among healthy individuals (n = 83),
but not stone formers (n = 132) (Hosking et al. 1985).
Another study in nonstone formers found that the daily
urinary excretion of citrate increased with age, to reach a
maximum during the fifth decade, then remaining rela-
tively constant thereafter until the eight decade when it
decreased (n = 197). However, only 14 individuals were
>60 years old (Trinchieri et al. 1992). Thus, to more
accurately assess age-related effects on urinary citrate
excretion, it may be important to distinguish between
stone formers and nonstone formers, since hypocitraturia
is found in 20–60% of persons with urinary stone disease
for reasons yet to be ascertained (Zuckerman and
Assimos 2009).
Kidney function together with renal ammoniagenesis
decreases with age resulting in more acidic urine, since
under these circumstances protons are disproportionately
excreted as titratable acids. Thus, perhaps not surpris-
ingly, urine pH also decreased with age in our study
(Table 2). However, the net effect of these changes on
systemic acid base balance is not clear, and the relation-
ship between urine pH, ammonium excretion, citrate
excretion, and normal aging is not necessarily predictable
(Zuckerman and Assimos 2009). Our finding of an asso-
ciation between eGFRCys and urinary citrate excretion
suggests the net effect is to reduce urine citrate (Table 3),
perhaps as part of the compensation for reduced urinary
ammonium excretion, and Gershman and colleagues also
reported that reductions in GFR are associated with
decreased urine citrate (Gershman et al. 2012).
Most importantly, we demonstrate for the first time that
having a higher fasting glucose is associated with higher
urinary citrate, but lower urine pH (Table 3). Although a
study by Pigna et al. (2014) did not find the correlation
between urinary citrate excretion and blood glucose
Table 2. Bivariate associations for urine citrate, pH, and net alkali
absorption.
Urine citrate,
mg/day Urine pH
Net alkali
absorption
b b mEq/day, b
Age, year 3.7251 0.003 0.2801
Sex (male) 96.2842 0.1733 14.8193
Weight, kg 3.4803 0.1913
Serum creatinine, mg/dL 222.4202 0.6333 6.343
eGFRCys, mL/min/1.73 m
2 3.6533 0.074
Blood glucose, mg/dL 3.9173 0.0073
Dietary measures
Total protein, g/day
Potassium, mg/day 0.023 0.00003 0.0033
Diuretic use
Loop (yes) 289.6203 0.3151 12.6401
Thiazide (yes) 65.1391 0.001
b, beta estimate, eGFR, estimated Glomerular Filtration Rate
(cystatin calculation);
1
P < 0.05.
2
P < 0.01.
3
P < 0.001.
Table 3. Multivariable associations for urine citrate, pH, and
net alkali absorption.
Urine citrate,
mg/day Urine pH
Net alkali
absorption
b b mEq/day, b
Intercept 670.952 7.253 21.15
Age, year 4.411 0.0008 0.583
Sex (male) 58.26 0.01 12.263
Weight, kg 3.943 0.162
Serum creatinine, mg/dL 144.39 0.53 2.29
eGFRCys, mL/min/1.73 m
2 4.193 0.213
Blood glucose, mg/dL 3.563 0.013
Dietary measures
Total protein, g/day 0.00453
Potassium, mg/day 0.02 0.00013 0.00333
Diuretic use
Loop (yes) 238.363 0.21 7.15
Thiazide (yes) 87.742
b, beta estimate, eGFR, estimated Glomerular Filtration Rate (cys-
tatin calculation).
1
P < 0.05.
2
P < 0.01.
3
P < 0.001.
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significant (P = 0.12), likely due to a low number of partic-
ipants (n = 21), the direction of effect was the same as that
in the current study. Similar findings were also reported in
a study of 252 stone formers (Daudon et al. 2006) in which
diabetic uric acid and calcium stone formers had higher
blood glucose and increased urinary citrate compared to
nondiabetic stone formers. Among calcium stone formers
urine pH was also significantly lower in the diabetic group
compared with nondiabetics. Nevertheless, in this study
blood glucose, but not diabetes status was an independent
predictor of urine citrate. It is possible that frank diabetes
has different effects on urine citrate, or that treatments for
diabetes may confound the association. However, some of
the effects of higher blood glucose are likely related to insu-
lin which stimulates glycolysis (Saltiel and Kahn 2001). The
increased citrate levels could stimulate acetyl-CoA carboxy-
lase and fatty acid synthesis (Martin and Vagelos 1962).
Intracellular citrate can eventually be metabolized to bicar-
bonate, with the net effect being inhibition of citrate reab-
sorption in the proximal tubule (Simpson 1967; Moseley
et al. 2013). However, insulin also alters adenosine triphos-
phate citrate lyase activity which converts citrate and CoA
to oxaloacetate and acetyl-CoA (Zuckerman and Assimos
2009; MacDonald et al. 2013). Overall, little is known
about the net effects of blood glucose and insulin on uri-
nary citrate excretion, and further studies are needed to
elucidate underlying mechanisms. Furthermore, medica-
tions that alter insulin sensitivity could also affect urinary
citrate and stone risk.
Mandel and colleagues performed a cross-sectional
study regarding urinary citrate on 2561 individuals from
three large cohorts (Health Professionals Follow-up Study
(HPFS), Nurses’ Health Studies (NHS I and II) and
found diabetes to be associated with higher urinary citrate
excretion in men and younger women (Mandel et al.
2013). It was hypothesized that citrate could be compet-
ing with glucose for proximal tubule reabsorption
through the sodium cotransport. The majority of citrate
reabsorption in the kidney is thought to occur through
NaDC1, a sodium-dependent dicarboxylate co-transporter
in the proximal tubule (also expressed in small intestinal
cells) (Pajor 1995; Ho et al. 2007). Since NaDC1 is also
responsible for reabsorption of other TCA cycle interme-
diates, it could indeed be related to citrate reabsorption
and glucose metabolism. Furthermore, our interaction
model also revealed that the effect of blood glucose on
urinary citrate excretion decreased with age (Fig. 4A),
raising questions regarding age-related changes in the
relation between citrate reabsorption and glucose. While
the effect of age on urinary citrate excretion was relatively
small in this study (b = 4.41), this relationship provides
important insights, since the relation between age and
urinary citrate interacted significantly with blood glucose
(Fig. 4A), suggesting glucose as an important factor.
Indeed having higher blood glucose diminished the effect
of age on urinary citrate.
Higher body weight was also associated with greater
urinary citrate excretion (Table 3). Powell and colleagues
studied 5942 stone formers of which 414 were obese
(>120 kg in males >100 kg in females) and also found
the obese group to have a higher 24-h urinary citrate
excretion (Powell et al. 2000). Conversely, Mandel and
colleagues found having high BMI was associated with a
lower urinary citrate (Mandel et al. 2013). Since we found
an effect of weight, but not BMI on urinary citrate in the
main effects model, it suggests that body habitus is
important. Citrate metabolism is known to be affected by
fatty acid synthesis (Martin and Vagelos 1962) and thus
could explain the increased citrate levels with higher
weight. Individuals with greater weight were also found
to have a steeper increase in urinary citrate levels at
higher levels of eGFRCys (Fig. 4B). This could be related
to the body weight itself and/or altered food intake mix
related to greater body weight. However, body habitus
could be more important than diet. A study in mice
found NaDC1/ animals demonstrated no significant
alteration in serum citrate levels, suggesting that meta-
bolic citrate production is more important than citrate
absorption via the gut (Ho et al. 2007).
A lower urinary pH has also been observed in those with
a higher BMI (Maalouf et al. 2004) and higher fasting glu-
cose (Otsuki et al. 2011). Insulin resistance and/or accu-
mulation of lipids in renal proximal tubular cells leading to
reduced renal ammoniagenesis have been implicated as fac-
tors contributing to these observations (Maalouf et al.
2010). These mechanisms likely contribute to the lower
urinary pH we observed with higher fasting glucose.
We found thiazide use associated with decreased uri-
nary citrate, as previously shown (Mandel et al. 2013).
This is likely caused by thiazide-induced hypokalemia,
which would stimulate citrate reabsorption in the proxi-
mal tubules (Zuckerman and Assimos 2009). Loop diure-
tic use also decreased urinary citrate (Table 3), probably
also due to hypokalemia. Thiazides were found to reduce
urinary citrate excretion more in males than females
(Fig. 4C), suggesting males taking thiazides might poten-
tially require closer monitoring for this complication.
Several interesting associations with urinary citrate
excretion were observed, some of which paralleled effects
on urine pH and others which did not. Urine pH
decreased with protein intake which can be explained by
the increased acid load from protein. Dietary potassium
increased urine pH, perhaps due to relatively higher
ingestion of fruits and vegetables (Pearle et al. 2014).
Our study has limitations. Participants were of Euro-
pean descent and of relatively older age. Eisner and
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colleagues found Asian/Pacific islander stone formers to
have less urinary citrate excretion than Whites (Eisner
et al. 2010). Our population was also largely nonstone
forming, however stone formers are likely to have altered
acid-base balance (Zuckerman and Assimos 2009) and
intentional diet changes. Also a fasting glucose would
ideally be obtained at the exact time of the urine collec-
tion. However, fasting glucose is not likely to change sig-
nificantly over a short period of time unless diabetes
status changes (e.g., with weight loss or gain). However,
it is also important to recognize that the observed associ-
ations of fasting blood glucose with urinary parameters
apply at a population level and point toward a physio-
logic mechanism, but cannot be used to predict urinary
parameters on an individual level due to within person
variability (Sacks 2011). Despite these limitations, the
current study benefits from a large sample size and
inclusion of dietary data. Studying healthy individuals
allowed us to examine the actual influence of age, sex
and other parameters on urinary citrate excretion, and
how changes in urinary citrate excretion can explain
trends in kidney stone events.
In conclusion, our study points toward the ambient
blood glucose concentration as having a measurable
unique influence on urinary citrate excretion and pH.
While age and weight also associated with urinary citrate
excretion, the effect of age interacted with blood glucose
levels, rather than reduced kidney function. A deeper
understanding of the relation between blood glucose and
urinary citrate excretion could increase our understanding
of the interrelationship between obesity, insulin resistance,
urinary citrate, and kidney stone risk.
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